Cash & equivalents increased 104.6%
Cash & equivalents changed +104.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +104.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current assets changed +62.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Current liabilities changed +45.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +19.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Operating income changed +34.9% from the comparable as-filed period.
Trade receivables changed +28.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed +24.4% from the comparable as-filed period.
Operating cash flow changed +25.0% from the comparable as-filed period.
Operating margin changed +409 basis points from the comparable as-filed period.
Shares outstanding changed -1.9% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Revenue changed +16.1% from the comparable as-filed period.
Debt / assets changed -377 basis points from the comparable as-filed period.
Receivables / revenue changed +326 basis points from the comparable as-filed period.
Capital expenditure changed +55.6% from the comparable as-filed period.
Cash / debt changed +8380 basis points from the comparable as-filed period.
Gross profit changed +16.6% from the comparable as-filed period.
SBC / revenue changed -184 basis points from the comparable as-filed period.
Debt / revenue changed -1961 basis points from the comparable as-filed period.
Working capital / assets changed +254 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed +12.3% from the comparable as-filed period.
Gross margin changed +42 basis points from the comparable as-filed period.
Net debt changed -421.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Operating cash-flow margin changed +201 basis points from the comparable as-filed period.
Working capital changed +11.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Free-cash-flow margin changed +184 basis points from the comparable as-filed period.
Current ratio changed +12.0% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Capex / revenue changed +17 basis points from the comparable as-filed period.
R&D / revenue changed -75 basis points from the comparable as-filed period.
Stock-based compensation changed -3.7% from the comparable as-filed period.
Gross debt changed +0.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Reported total debt changed +0.0% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Revenue changed +18.4% from the comparable as-filed period. The change ranks at the 81th percentile of 146 prior comparable changes.
Operating margin changed +1370 basis points from the comparable as-filed period. The change ranks at the 84th percentile of 146 prior comparable changes.
Operating income changed +132.2% from the comparable as-filed period. The change ranks at the 79th percentile of 146 prior comparable changes.
Operating cash flow changed +58.3% from the comparable as-filed period. The change ranks at the 58th percentile of 80 prior comparable changes.
Gross margin changed +75 basis points from the comparable as-filed period. The change ranks at the 45th percentile of 146 prior comparable changes.
Gross profit changed +19.4% from the comparable as-filed period. The change ranks at the 78th percentile of 146 prior comparable changes.
Free-cash-flow proxy changed +57.6% from the comparable as-filed period. The change ranks at the 64th percentile of 50 prior comparable changes.
Cash & equivalents changed +47.1% from the comparable as-filed period. The change ranks at the 90th percentile of 260 prior comparable changes.
Capital expenditure changed +112.5% from the comparable as-filed period. The change ranks at the 92th percentile of 50 prior comparable changes.
Net income changed +223.0% from the comparable as-filed period. The change ranks at the 84th percentile of 188 prior comparable changes.
Capex / revenue changed +39 basis points from the comparable as-filed period. The change ranks at the 30th percentile of 50 prior comparable changes.
Research & development changed +6.9% from the comparable as-filed period. The change ranks at the 34th percentile of 146 prior comparable changes.
Debt changed +8.7% from the comparable as-filed period. The change ranks at the 57th percentile of 51 prior comparable changes.
Stock-based compensation changed -32.6% from the comparable as-filed period. The change ranks at the 74th percentile of 139 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.